Navigation Links
Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from,2006 Presented at Digestive Disease Week in Washington, D.C.

SOUTH SAN FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Napo Pharmaceuticals, Inc., , which focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace in collaboration with local partners, announced that Trine Pharmaceuticals, Inc. ("Trine") is presenting a poster detailing the results of a Phase 2a study conducted in 2006 for crofelemer for diarrhoea predominant irritable bowel syndrome (d-IBS) today at Digestive Disease Week in Washington, D.C. Trine licensed crofelemer for the d-IBS indication from Napo in June 2004. Trine has worldwide development and commercialization rights to crofelemer for d-IBS. The objective of the trial was to evaluate the safety and efficacy of crofelemer in men and women with d-IBS.

The trial was designed as a randomized double-blind placebo-controlled, dose-ranging (placebo, 125 mg, 250 mg, and 500 mg bid) study over a 12-week treatment period in 246 patients with d-IBS (Rome II criteria), including both males and females, whose average age was 50 years old.

IBS symptoms (pain, urgency, stool frequency and consistency, and adequate relief) were self-reported by the patients via an interactive voice response system (IVRS). Patients needed to exhibit active disease during the two-week baseline period as defined by a mean daily stool frequency greater than or equal to 2/day, pain score greater than or equal to 1 and stool consistency greater than or equal to 3 (5-point Lickert scale for pain and consistency) to be enrolled. Patients received treatment for 12 weeks followed by a two-week treatment free period.

Results: The 125 mg bid of crofelemer exhibited a consistent response during each month among most efficacy endpoints in women with d-IBS (see table) reaching statistical significance (p<0.05) for pain. Crofelemer had little effect on the stool consistency score, though there was a trend toward redu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:10/7/2008)...alif., Oct. 7 /- Aerovance Inc. today...m a Phase I trial of its Aerovant,inhalation powde...nce of,local irritancy following asthma patients, ...se will be the highest of three doses investigated...h is scheduled to begin early,next year. Evidence ...
(Date:10/7/2008)...panded to Eight On-Demand Tests for Use on the Gen... SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ ...ase of Xpert(TM) vanA/vanB as a European CE,IVD Ma...o Diagnostic,Medical Devices. The test delivers ra... most commonly associated with vancomycin-resistan...
(Date:10/6/2008).... 6 /PRNewswire-USNewswire/ -- "A return to the us...lopment is without scientific,justification," acco...ernatives to Laboratory Animals (ATLA). "An Assess...search" concludes that vaccine responses in,chimpa...nd that claims of,chimpanzees, critical role and i...
(Date:10/6/2008)...ss Promising Research at The American College of N...g, WASHINGTON, Oct. 6 /- New researc...niors was presented at The American College of,Nut...ical Applications of,Probiotics in Health and Dise...cs, aging, and nutrition discussed the potential u...
Breaking Medicine Technology:Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Bushs Budget Proposal Would Cut Medicare Funding 10974 1Bushs Budget Proposal Would Cut Medicare Funding 10974 2Bushs Budget Proposal Would Cut Medicare Funding 10974 3Bushs Budget Proposal Would Cut Medicare Funding 10974 4Over 300 Children Are Given New Smiles 10972 1Over 300 Children Are Given New Smiles 10972 2Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 1Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 2Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 3Will This President Never Learn 3F Another Budget Another Increase to Ineffective Abstinence Only Programs 10968 1Will This President Never Learn 3F Another Budget Another Increase to Ineffective Abstinence Only Programs 10968 2
...YTON, Ohio, June 08, 2007,/PRNewswire-FirstCall/ -...tic Fibrosis Society Annual,Meeting. ..., -- Exocrine pancreatic insufficiency (EPI) is...lly produced by,the pancreas that can result from ...ibrosis, chronic pancreatitis, and , , pancr...
... Patients Taking Trexima were Migraine Free,Compar... -- New data from two large,trials show that Trexi...e as placebo in eliminating all traditional migrai...attacks with just,one tablet. The findings will be...Meeting of the American Headache Society. , In add...
Other Medicine Technology:Eurand to Present Zentase Phase III Data 2Eurand to Present Zentase Phase III Data 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 4
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...You might call this a professional car wash salon ...ane has a sexy lady at the wheel, going swish swas... And if thats not enough to give the lady (your c... choose a nude lady car washer to strip your car o...
...Transformational contribution to support new clini...n Johns Hopkins officials today announced a signif...ne from His Highness Sheikh Khalifa bin Zayed Al ... (UAE). Most of the gift, made in honor of Sheikh ...
...The link between environmental exposures and asthm... researchers at the Harvard School of Public Healt...ic violence and asthma. The study, in the upcomin...emiology, raises questions about the role of stres...
...More research is needed to determine the true effe...developing fetus, and the impact on pregnant women...pregnancy, child health researchers say. Recomme... during pregnancy vary across English-speaking cou...
Other Medicine News:Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 2Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 3Health News:Research Demonstrates Link Between Domestic Violence and Asthma 2Health News:Better Research Needed On Alcohol In Pregnancy 2
...eica ASP200 is an advanced smart processor for par...ne histopathology applications. Proven and enhance... smart operating software are the hallmark of the ...ed and the software includes a variety of SMART fe...
The electronic, motorized rotary microtomes are designed for all applications of paraffin, semi-thin (HM 360), and hard specimens in clinical, research, and industrial labs. These instruments display
...eica RM2255 rotary microtome, designed for fully m...bedded specimens, offers a broad application spect...ory. This microtome meets the requirements of user...c microtome for their laboratory. The entire acces...
State-of-the-Art modular embedding station providing performance and ease of use to meet the needs of the most demanding user.
Medicine Products: